Advancing approaches to identify young children at risk for post-discharge mortality: Protocol for a prospective

Kitiezo Aggrey Igunza1, Adrianna L Westbrook2, Harun Owuor1

  • 1Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.

BMJ Paediatrics Open
|November 10, 2025
PubMed

Insights

Post-discharge mortality (PDM) in young children in sub-Saharan Africa is a critical issue. This study validates risk tools and examines endothelial dysfunction marker, global arginine bioavailability ratio (GABR), for predicting PDM.

Area of Science:

  • Pediatric mortality
  • Global health
  • Biomarkers

Background:

  • Childhood mortality after hospital discharge is high in sub-Saharan Africa.
  • Validated tools to predict post-discharge mortality (PDM) are lacking.
  • Endothelial dysfunction is a common pathway for PDM.

Purpose of the Study:

  • To externally validate existing risk assessment tools for 60-day PDM.
  • To investigate the association between global arginine bioavailability ratio (GABR) and 60-day PDM.

Main Methods:

  • Prospective observational cohort study of 2000 children (0-59 months) in Western Kenya.
  • Systematic review identified candidate variables for risk tools; plasma samples collected at discharge.
  • Telephone follow-up at 30 and 60 days to determine vital status; GABR measured.

Main Results:

  • Validation of risk assessment tools for PDM is ongoing.
  • Association between GABR and PDM will be analyzed using conditional logistic regression.

Conclusions:

  • Accurate prediction of PDM is crucial for targeted interventions.
  • GABR may serve as a novel biomarker for endothelial dysfunction in children at risk of PDM.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
547
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
254